Corpus Intelligence IC Memo — BRYN MAWR REHABILITATION HOSPITAL 2026-04-26 08:05 UTC
IC Memo — BRYN MAWR REHABILITATION HOSPITAL
Investment Committee Memorandum | PA | 148 beds | Grade C | EBITDA uplift $6.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BRYN MAWR REHABILITATION HOSPITAL

CCN 393025 | CHESTER, PA | 148 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BRYN MAWR REHABILITATION HOSPITAL is a 148-bed suburban community hospital in CHESTER, PA with $81.2M in net patient revenue and a -5.8% operating margin. The hospital serves a payer mix of 41.6% Medicare, 1.1% Medicaid, and 57.3% commercial.

Thesis: Undervalued. Our ML models identify $6.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.8% to 1.5% (+736bps).

Net Revenue HCRIS$81.2M
Current EBITDA COMPUTED$-4.8M
Operating Margin COMPUTED-5.8%
Occupancy HCRIS64.6%
Revenue / Bed COMPUTED$549K
Net-to-Gross HCRIS28.7%
Distress Probability ML45.6%

2. Market Context & Competitive Position

225
PA Hospitals
-4.4%
State Median Margin
101
Comparable Hospitals

PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of -5.8% places it below the state median. Among 101 size-comparable peers (74-296 beds), the median margin is -8.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (74-296), prioritizing same-state peers. 101 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BRYN MAWR REHABILITATION HOSPI (Target)PA148$81.2M-5.8%
WESTERN PENNSYLVANIA HOSPITALPA255$776.4M11.1%
COMMUNITY MEDICAL CENTERPA266$474.1M3.1%
ROBERT PACKER HOSPITALPA252$471.8M-2.1%
WILLIAMSPORT HOSPITAL & MEDICAPA227$459.8M-8.4%
CROZER CHESTER MEDICAL CENTERPA296$459.6M-19.6%
MOUNT NITTANY MEDICAL CENTERPA248$441.7M12.6%
MEMORIAL MEDICAL CENTERPA241$435.1M-21.2%
THE CHAMBERSBURG HOSPITALPA234$435.1M5.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.7M+210bp18mo
Cost to Collect4.5%2.5%$1.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$989K+122bp9mo
Clean Claim Rate88.0%96.0%$52K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.7M
Cost to Collect
$1.6M
Denial Rate Reduction
$1.6M
A/R Days Reduction
$989K
Clean Claim Rate
$52K
Total EBITDA Uplift$6.0M
Current EBITDA$-4.8M
+ RCM Uplift+$6.0M
Pro Forma EBITDA$1.2M
Current Margin-5.8%
Pro Forma Margin1.5%
WC Released (1x)$3.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-7.3M$28.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-7.3M$28.9M0.00x-100.0%
Bull Case9.0x11.0x$-6.6M$46.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-6.6M$48.6M0.00x-100.0%
Bear Case11.0x10.0x$-8.0M$929K0.00x-100.0%
Bear (11x exit)11.0x11.0x$-8.0M$-1.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 101 hospitals with 74-296 beds
  • Same-state prioritization (n=102)
  • Comp margins: P25=-19.2% / P50=-8.0% / P75=4.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.